Business Context and Reporting Period
Company: Intelligent Bio Solutions Inc. (INBS)
Filing Type: Form 8-K (Current Report)
Report Date: May 13, 2026
Reporting Period: Fiscal quarter ended March 31, 2026
Context: The Company issued a press release announcing financial results for the quarter ended March 31, 2026, furnished as Exhibit 99.1 to this filing.
Key Financial Metrics
The provided Form 8-K text serves as a cover document referencing a press release (Exhibit 99.1) but does not contain the specific financial data within the text itself. Consequently, the following metrics are not available in the source text:
- Revenue: Not provided in filing text.
- Profit/Loss: Not provided in filing text.
- Cash Flow: Not provided in filing text.
- Margins: Not provided in filing text.
- Debt and Liquidity: Not provided in filing text.
Material Changes
The filing text does not provide specific numerical comparisons or descriptions of material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for this information.
Guidance, Outlook, and Risks
Guidance and Outlook: The filing text does not contain management commentary, forward-looking guidance, or outlook statements.
Risks and Contingencies: No specific risks or contingencies are detailed in the provided text.
Unusual Items: No unusual items are described in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 13, 2026) for actual revenue, net income, and cash flow figures.
- Verify the specific year-over-year and quarter-over-quarter performance metrics not included in the 8-K cover page.
- Check for any updated forward-looking guidance or strategic shifts mentioned in the press release.
- Confirm the Company's status as an Emerging Growth Company (indicated as checked in the filing) and its implications for financial reporting standards.